Sinovac deaths, BioNTech better at curbing spread of coronavirus

Uruguay, which started vaccination studies on March 1, shared with the public the preliminary findings it obtained among people who received two doses of vaccine. The efficacy of Sinovac and BioNTech vaccines has been announced.

A study was conducted on Sinovac in Uruguay. As a result of the research conducted by the Uruguayan Ministry of Health, it was determined that Sinovac was more effective in preventing the transmission of the virus than the BioNTech/Pfizer vaccine in preventing deaths due to coronavirus.

Uruguay began immunization efforts on 1 March. The study was based on general data from people across Uruguay who had received two doses of the vaccine and were 14 days old. Sinovac vaccine was administered to approximately 712 thousand people and BioNTech/Pfizer vaccine was administered to approximately 150 thousand people . A total of 862 thousand people were evaluated. While the BioNTech/Pfizer vaccine was administered to the elderly and healthcare workers, the other group was administered the Sinovac vaccine. The ministry reported that the results obtained with the two vaccines are not directly comparable, as those administered the Pfizer/BioNTech vaccine in Uruguay are in the higher-risk categories.

People with the BioNTech/Pfizer vaccine reduced the risk of contracting the virus by 75 percent, and the Sinovac vaccine by 57 percent. BioNTech/Pfizer reduced the risk of being admitted to intensive care by 99 percent, and Sinovac by 95 percent.

14 people who were vaccinated died due to


In reducing the death rate from coronavirus , Sinovac was successful by 97 percent, while the BioNTech/Pfizer vaccine reduced it by 80 percent. While 5 thousand 360 people out of 712 thousand 716 people who were vaccinated with Sinovac were infected with the virus, 6 of the 19 people who were taken to the intensive care unit died. In the research, it was determined that 691 people out of 149 thousand 329 people who were vaccinated with BioNTech/Pfizer were infected with the virus, one person was treated in the intensive care unit, and 8 people died. It was emphasized that people who lost their lives despite being vaccinated with BioNTech were in their 80s.

Researchers stated that other diseases carried by the deceased are not taken into account and only deaths caused by coronavirus are included in the research. Pointing out that these factors have a great impact on mortality rates, experts stated that not taking these points into account may affect the results of the research.

Uruguay, with a population of 3.5 million, vaccinated 862 thousand people until May 25, vaccinating 45.8 percent of the risky group In Uruguay, which is trying to beat the virus without applying quarantine, 3,518 new cases and 52 new deaths have been announced in the last 24 hours.

Write a Comment